Riskpilot← Back to searchSign inGet full accessEPIVITY SUPPLEMENTS AS
ASActiveOrg 934078640Kirkeveien 64A, 0364 OsloOther human health activities n.e.c. · NACE 8699Est. 2024— employees
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
-8.5%
Financial strength
Net profit 2024
NOK -50K
| Revenue | NOK 0 | — |
| EBITDA | NOK -45K | — |
| Net profit | NOK -50K | — |
| Total assets | NOK 322K | — |
| Equity | NOK -28K | — |
| Employees | — | — |
Legal name
EPIVITY SUPPLEMENTS AS
Org number
934078640
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
11. september 2024
Share capital
NOK 30 000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Importere og selge helsekostprodukter, andre helserelaterte produkter og helserelaterte teknologi produkter, hovedsakelig produkter som har som mål å bremse ned eller reversere biologisk aldring slik at man kan leve et bedre, lengre og friskere liv. Selskapet kan også investere i forskning innen dette området.
Address
Kirkeveien 64A, 0364 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | 0 |
| Staff expenses | −0 |
| EBITDA | −45 |
| Depreciation & amort. | −6 |
| EBIT | −50 |
| Net financials | −0 |
| Profit before tax | −50 |
| Tax | −0 |
| Net profit | −50 |
| Item | 2024 |
|---|---|
| Total assets | 322 |
| Equity | −28 |
| Long-term debt | 350 |
| Short-term debt | 0 |
| Total debt | 350 |
EBITDA margin
-4453100.0%
This company
15.8%
Market median
-28184277% vs market
20242024
Equity ratio
-8.5%
This company
38.2%
Market median
-122% vs market
20242024
Return on equity
-5036300.0%
This company
18.4%
Market median
-27371296% vs market
20242024
Net profit margin
-5036300.0%
This company
8.1%
Market median
-62176643% vs market
20242024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242024
Debt / equity
12.73×
This company
0.62×
Market median
-1953% vs market
20242024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MS Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Epivity Health As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fantur As
EPIVITY SUPPLEMENTS AS Board members of EPIVITY SUPPLEMENTS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Sandberg | Chief Executive Officer | 0 companies |
| Hanne Serine Finstad | Board of Directors | 0 companies |
| Jan Einar Vaage | Board of Directors | 0 companies |
| Ruth Foseide Thorkildsen | Board of Directors | 0 companies |
| Preben Brecke | Chairman | 0 companies |